Expanded access program (EAP) to investigational drugs

Reviewer: Maria Luisa Veronese, MD
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 6 de junio del 2004

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

FDA Approves Expanded Use for Melanoma Drug

Oct 30, 2015

Yervoy can now be used after surgery to reduce risk of skin cancer returning

FDA Expands Imbruvica Approval to Include CLL

Feb 14, 2014

Approval of Imbruvica (ibrutinib) expanded to include people with chronic lymphocytic leukemia

ASCO: Demand for Quality Cancer Care Increasing

Mar 12, 2014

Millions lack access to quality care; one-quarter of uninsured forgo care because of costs